Cripto: a common regulator for cancer and stem cells
Nature Communications - Colomed researchers participated in a study published on Nature Communications, 2 September 2016. The study shows that Cripto protein ...
News
-
-
FOLFIRI+cetuximab vs FOLFIRI+bevacizumab for metastatic CRC
The Lancet Oncology - A team of German doctors has compared two different treatment regimens for metastastic colon cancer phase ...
-
Colorectal Cancer on the Decline — Why Screening Can’t Explain It All
The New England Journal of Medicine - On the most important American medical journal, two experts show that in the USA colorectal cancer incidence ...
-
A recellularized human colon model identifies cancer driver genes
Nature Biotechnologies - A group of researchers from different countries has created an artificial colon model which allowed them to ...
